Lawsonia intracellularis Infection in Swine: Pathogenesis, Clinical Presentation, Diagnosis, and Management

Etiology and Taxonomy

Lawsonia intracellularis is an obligate intracellular, gram-negative bacterium belonging to the Desulfovibrionaceae family within the Deltaproteobacteria class [1, 2]. The organism is the etiological agent of porcine proliferative enteropathy (PPE), a globally significant enteric disease of swine [3, 4]. The bacterium is curved to rod-shaped, measures approximately 1.25 to 1.75 µm in length, and possesses a single polar flagellum [2, 5]. Its obligate intracellular nature necessitates culture in cell lines such as IEC-18 or McCoy cells, which has facilitated isolation and characterization of strains from diverse geographic regions [2, 5]. The species is genetically homogeneous, though pangenomic analyses have identified species-specific antigens with vaccine potential [6, 7].

Epidemiology and Transmission

The global distribution of L. intracellularis is well documented, with seroprevalence studies demonstrating high infection pressure in commercial swine operations [4, 8, 9]. In Brazil, a seroprevalence study of subsistence farms in Minas Gerais reported risk factors including lack of biosecurity measures and mixed-age housing [9]. Similarly, Greek pig farms show high seropositivity for L. intracellularis, often co-associated with Ascaris suum exposure [10]. In South Korea, L. intracellularis is among the most frequently detected pathogens in clinical samples from diarrheic pigs [4]. Transmission dynamics are primarily fecal-oral, with the bacterium shed in high numbers in feces of infected pigs [3, 11]. Environmental contamination is a major reservoir; recent evidence demonstrates detection of L. intracellularis in air samples from commercial swine farms, suggesting potential airborne dissemination [11]. Piglets can acquire infection early in life, with molecular detection possible in suckling piglets before weaning [12]. Co-infection with other enteric pathogens such as Brachyspira hyodysenteriae or porcine circovirus type 2 (PCV2) is common and exacerbates clinical severity [13, 14, 15]. Risk factors for farm-level infection include high stocking density, continuous flow production, poor hygiene, and lack of vaccination [8, 16, 17].

Pathogenesis

Lawsonia intracellularis targets the immature enterocytes of the intestinal crypts, primarily in the ileum, cecum, and proximal colon [1, 18, 19]. Following oral ingestion, the bacterium adheres to and invades the apical surface of enterocytes, an event dependent on host cell endocytosis [20]. Once internalized, the organism escapes the endocytic vacuole and multiplies freely within the cytoplasm of the host cell [20, 21]. Intracellular survival involves modulation of host signaling pathways, particularly the nuclear factor-kappa B (NF-κB) pathway, which the bacterium manipulates to avoid innate immune clearance [20]. Additionally, L. intracellularis secretes effector proteins, including LI0666, which contains EPIYA motifs and is exported via a type III secretion system, mimicking eukaryotic signaling to promote intracellular persistence [21].

Infected enterocytes undergo profound hyperplasia rather than cell death, leading to marked thickening of the intestinal mucosa, a hallmark of PPE [1, 18]. The proliferative response was historically hypothesized to involve canonical Wnt signaling, but studies have demonstrated that canonical Wnt signaling is not activated during L. intracellularis infection either in vitro or in vivo [18]. Instead, the bacterium drives epithelial proliferation through alternative mechanisms involving NF-κB modulation and possibly other mitogenic pathways [20, 19].

The resulting pathological lesions include thickened, corrugated mucosa of the ileum and colon, with histological findings of elongated, hyperplastic crypts containing numerous basophilic intracellular bacteria [1, 14]. In severe cases, granulomatous and necrotic lesions develop, as observed in a pig with proliferative and granulomatous ileitis [1]. Co-infection with B. hyodysenteriae synergistically worsens lesions and alters the gut microbiome composition [14].

Clinical Presentation

The clinical spectrum of swine lawsonia intracellularis infection ranges from subclinical to acute hemorrhagic forms. The classic presentation is an acute or chronic diarrheal disease affecting weaner to finisher pigs, typically between 6 and 20 weeks of age [3, 8]. Chronic PPE (porcine intestinal adenomatosis) is characterized by mild to moderate diarrhea, reduced feed conversion, weight loss, and variable mortality [17]. The acute hemorrhagic form (proliferative hemorrhagic enteropathy) presents with swine bloody diarrhea, sudden onset of dark, bloody feces, pale mucous membranes, and sudden death in finisher pigs or young adults [2, 15]. This hemorrhagic form is associated with intestinal hemorrhage from hyperplastic crypts. Affected pigs may also show anorexia, depression, and dehydration. Fever is inconsistent but may occur in acute cases [15]. In herds with subclinical infection, performance parameters such as average daily gain and feed efficiency are impaired even without overt diarrhea [16, 17].

Pathology

Gross pathological lesions are predominantly confined to the terminal ileum, cecum, and proximal colon. The affected intestinal wall is thickened, edematous, and the mucosa is thrown into prominent transverse or longitudinal folds giving a corrugated appearance [1, 14]. The lumen may contain blood and fibrin clots in acute hemorrhagic cases. Serosal surface may appear normal or congested. Histopathology reveals crypt hyperplasia with elongated, branching crypts lined by immature columnar epithelial cells containing intracytoplasmic, argyrophilic organisms [1, 19]. In chronic cases, granulomatous inflammation and fibrosis may be observed [1]. In co-infections with PCV2, additional features of lymphoid depletion and inclusion bodies may be present [15].

Diagnosis

Accurate diagnosis of L. intracellularis infection relies on a combination of clinical history, gross pathology, histopathology, and molecular or serological testing.

Histopathology and Immunohistochemistry

Histological examination of ileal sections stained with Warthin-Starry silver stain reveals the characteristic intracellular bacteria within hyperplastic crypt epithelium [1, 14]. Immunohistochemistry using specific monoclonal or polyclonal antibodies provides high specificity and allows confirmation of infection in formalin-fixed tissues [15].

Molecular Detection

Quantitative PCR (qPCR) is the gold standard for detection of L. intracellularis DNA in feces or intestinal tissues [22, 23, 12]. Singleplex qPCR assays targeting conserved regions such as the asd gene have been developed and applied in field studies [22]. Multiplex real-time PCR assays simultaneously detect L. intracellularis, B. hyodysenteriae, and Clostridium perfringens or porcine epidemic diarrhea virus, enabling differential diagnosis in cases of swine bloody diarrhea [23, 24]. A triplex TaqMan-based method offers high sensitivity and specificity for outbreak investigations [23, 24].

Serology

Serological assays detect antibodies against L. intracellularis in serum or plasma. The indirect immunofluorescence antibody test (IFAT) and commercial ELISA kits are commonly used [25, 13, 26]. A flow cytometry antibody test provides quantitative serological assessment with high throughput [26]. Acute phase proteins such as C-reactive protein and haptoglobin have also been evaluated as non-antibody systemic biomarkers of infection [27].

Culture and Isolation

In vitro isolation of L. intracellularis is laborious and requires specialized cell culture systems, but has been achieved using IEC-18 cells under microaerophilic conditions [2, 5]. Isolates from China have shown varying pathogenicity in experimental infections [2, 5].

Differential Diagnosis

Diarrhea in pigs with L. intracellularis infection must be differentiated from other causes of enterocolitis, including Brachyspira hyodysenteriae (swine dysentery), Salmonella enterica serovar Typhimurium, Clostridium perfringens type A or C, porcine epidemic diarrhea virus, transmissible gastroenteritis virus, and rotavirus [4, 23, 14]. Co-infections are common and complicate clinical diagnosis [13, 14, 15]. The presence of black, tarry feces and sudden death in finisher pigs strongly suggests the hemorrhagic form of PPE.

The following diagram illustrates a diagnostic decision tree for a pig presenting with diarrhea:

flowchart TD
    A[Pig with diarrhea or bloody stools], > B{Clinical signs consistent with PPE?}
    B, >|Yes| C[Fecal or tissue sample]
    C, > D[qPCR for L. intracellularis]
    D, > E{Positive?}
    E, >|Yes| F[Confirm diagnosis of PPE]
    E, >|No| G[Consider other enteric pathogens]
    G, > H[Multiplex PCR for Brachyspira, Clostridium, Salmonella, viruses]
    H, > I[Treat accordingly]
    F, > J[Assess severity and treatment options]

Management and Treatment

Antimicrobial Therapy

Treatment of acute PPE relies on antimicrobials effective against intracellular bacteria. Macrolides (e.g., tylosin, tilmicosin), pleuromutilins (tiamulin), and tetracyclines (oxytetracycline) are commonly used [28, 29]. Tilmicosin-loaded sodium alginate/gelatin composite nanogels modified with guar gum have been developed to enhance therapeutic efficacy by targeting the ileal mucosa and sustaining drug release [28]. In-feed antibiotics such as tiamulin or chlortetracycline can be used for metaphylaxis during outbreaks [16]. However, antimicrobial resistance concerns and regulatory pressures are driving research into non-antibiotic alternatives [29].

Vaccination

Vaccination is a cornerstone of L. intracellularis control. Commercial live attenuated vaccines administered via oral drench (e.g., Enterisol Ileitis) are widely used [25, 16, 17]. A systematic review demonstrated that commercial and test vaccines reduce clinical signs and improve immunological parameters [25]. Intramuscular vaccination in naturally infected herds improves productivity and reduces antimicrobial consumption [16, 17]. Novel vaccine approaches include live attenuated candidates [30], subunit vaccines based on outer membrane proteins [31], and water-in-oil emulsion subunit vaccines that mitigate disease parameters but may not reduce shedding [32]. Combination vaccines for intradermal delivery against PCV2 and Mycoplasma hyopneumoniae can be co-administered with L. intracellularis vaccine [33]. Immunoinformatic approaches have identified B- and T-cell epitopes for subunit vaccine design [7]. A pangenomic reverse vaccinology method identified LAW_RS03650 as a species-specific novel antigen [6]. Intradermal administration with adjuvants enhances innate and adaptive responses [34]. A Salmonella vector expressing L. intracellularis antigens elicits protective immunity in a murine model [35].

Biosecurity and Control

Control of L. intracellularis on farms relies on all-in/all-out management, rigorous cleaning and disinfection, and vaccination [3, 8]. Risk factor analysis indicates that continuous flow, poor hygiene, and high pig density increase prevalence [8, 9]. A recent study quantified transmission dynamics, highlighting the rapid spread within groups and the importance of early detection [3]. Monitoring of shedding by qPCR in suckling piglets can identify early infections and guide intervention timing [12].

Conclusion

Lawsonia intracellularis remains a major cause of economic loss in swine production worldwide. Advances in molecular diagnostics, including multiplex qPCR and flow cytometry serology, have improved diagnostic accuracy. Understanding the pathogenesis at the molecular level, including modulation of NF-κB and secretion of EPIYA effectors, provides targets for novel therapeutics. Vaccination, combined with strict biosecurity, offers the most sustainable approach to controlling swine lawsonia intracellularis infection and its clinical manifestations such as swine bloody diarrhea.

References

[1] Horváth DG, Jeckel S, Segalés J, et al. Proliferative and granulomatous ileitis in a pig naturally infected with Lawsonia intracellularis. Porcine Health Manag. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42304539/

[2] Xie R, Luo Y, Peng C, et al. Isolation, passage, and pathogenicity of a newly isolated Lawsonia intracellularis strain from Hubei, China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40630509/

[3] Leite FL, Galvis JA, Beckler D, et al. Evaluation of the transmission dynamics of Lawsonia intracellularis in swine. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41916197/

[4] Wang HY, Song JK, Shin S, et al. Prevalence of pathogens from clinical samples associated with porcine respiratory and digestive diseases in South Korea from 2021 to 2023. Front Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40661171/

[5] Xiao N, Li J, Li M, et al. Isolation and in vitro cultivation of Lawsonia intracellularis from China. Vet Microbiol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35609389/

[6] Yin X, Yu X, Yan C, et al. LAW_RS03650: a species-specific novel antigen of Lawsonia intracellularis revealed via pangenomic reverse vaccinology method and serologically validated. Arch Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41831050/

[7] Khatooni Z, Broderick G, Anand SK, et al. Combined immunoinformatic approaches with computational biochemistry for development of subunit-based vaccine against Lawsonia intracellularis. PLoS One. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39992906/

[8] Jinanan J, Bosnjak-Neumüller J, Steiner T, et al. Risk association of Lawsonia intracellularis in commercial swine farms. Trop Anim Health Prod. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39976762/

[9] Barbosa JCR, Nicolino RR, Gabardo MP, et al. Subsistence swine farming: seroprevalence and risk factors associated with Lawsonia intracellularis infection in the state of Minas Gerais Brazil in 2016. Trop Anim Health Prod. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37736780/

[10] Tassis P, Symeonidou I, Gelasakis AI, et al. Serological assessment of Ascaris suum exposure in Greek pig farms and associated risk factors including Lawsonia intracellularis. Pathogens. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36145391/

[11] López-Lorenzo G, Carvajal A, Benito AA, et al. First evidence of Lawsonia intracellularis detection in air from commercial swine farms. Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41360279/

[12] Rodriguez-Vega V, Puente H, Carvajal A, et al. Detection and quantification by molecular techniques of early infection by Lawsonia intracellularis in suckling piglets. Porcine Health Manag. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39380126/

[13] Chagas S, Jensen P, Paladino E, et al. Immune response of pigs vaccinated against proliferative enteropathy and co-infected with Lawsonia intracellularis and Brachyspira hyodysenteriae. Animals (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41514801/

[14] Daniel AGS, Pereira CER, Dorella F, et al. Synergic effect of Brachyspira hyodysenteriae and Lawsonia intracellularis coinfection: anatomopathological and microbiome evaluation. Animals (Basel). 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37627402/

[15] D'Annunzio G, Ostanello F, Muscatello LV, et al. Porcine Lawsonia intracellularis ileitis in Italy and its association with porcine circovirus type 2 (PCV2) infection. Animals (Basel). 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37048426/

[16] Musse SL, Nielsen GB, Stege H, et al. Productivity parameters, antimicrobial consumption, and prevalence of enteric pathogens before and after intramuscular vaccination against Lawsonia intracellularis in naturally infected Danish weaner and finisher pig herds. Prev Vet Med. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37451064/

[17] Musse SL, Nielsen GB, Stege H, et al. Effect of intramuscular vaccination against Lawsonia intracellularis on production parameters, diarrhea occurrence, antimicrobial treatment, bacterial shedding, and lean meat percentage in two Danish naturally infected finisher pig herds. Prev Vet Med. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36680993/

[18] Klaeui C, Resende TP, Gebhart CJ, et al. Canonical Wnt signaling is not activated in vitro or in vivo by Lawsonia intracellularis infection. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41558228/

[19] Kirthika P, Park S, Jawalagatti V, et al. Evaluation of host and bacterial gene modulation during Lawsonia intracellularis infection in immunocompetent C57BL/6 mouse model. J Vet Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35332712/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[20] Yang HW, Hu T, Ait-Ali T. Lawsonia intracellularis regulates nuclear factor-κB signalling pathway during infection. PLoS One. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39325775/

[21] Chen C, Dai Y, Yang Y, et al. Lawsonia intracellularis LI0666 is a new EPIYA effector exported by the Yersinia enterocolitica type III secretion system. Vet Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35659762/

[22] Xiao C, Wang Y, Chen T, et al. Development and application of a qPCR assay for Lawsonia intracellularis in Tibetan pigs. Front Cell Infect Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41416112/

[23] Wu W, Wang L, Xie R, et al. Development and application of a triplex real-time PCR method for the detection of Lawsonia intracellularis, Brachyspira hyodysenteriae, and Clostridium perfringens. Microbiol Spectr. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40366193/

[24] Ren J, Li F, Yu X, et al. Development of a TaqMan-based multiplex real-time PCR for simultaneous detection of porcine epidemic diarrhea virus, Brachyspira hyodysenteriae, and Lawsonia intracellularis. Front Vet Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39205809/

[25] de Oliveira Possa L, Romagnoli VDS, Senra RL, et al. Efficiency of commercial and test vaccines against Lawsonia intracellularis on clinical and immunological parameters in swine: a systematic review. Braz J Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42012559/

[26] Baldasso DZ, Guizzo JA, Dazzi CC, et al. Development and validation of a flow cytometry antibody test for Lawsonia intracellularis. Front Immunol. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37033985/

[27] Heegaard PMH, Starbæk SMR, Lelli D, et al. Pig acute phase proteins as non-antibody systemic biomarkers of intracellular infections. Methods Mol Biol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38888777/

[28] Luo W, Meng K, Zhao Y, et al. Guar gum modified tilmicosin-loaded sodium alginate/gelatin composite nanogels for effective therapy of porcine proliferative enteritis caused by Lawsonia intracellularis. Int J Biol Macromol. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37245769/

[29] de Groot N, Meneguzzi M, de Souza B, et al. In vitro screening of non-antibiotic components to mitigate intestinal lesions caused by Brachyspira hyodysenteriae, Lawsonia intracellularis and Salmonella enterica serovar Typhimurium. Animals (Basel). 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36139216/

[30] Lin H, Liu X, Yuan J, et al. Evaluation of a newly developed live attenuated vaccine candidate against Lawsonia intracellularis. Vaccines (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41600931/

[31] Aves KL, Fresno AH, Nisar S, et al. Outer membrane proteins as vaccine targets against Lawsonia intracellularis in piglets. Vaccines (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40006753/

[32] Fourie KR, Jeffery A, Chand D, et al. Vaccination with a Lawsonia intracellularis subunit water in oil emulsion vaccine mitigated some disease parameters but failed to affect shedding. Vaccine. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39213981/

[33] Hangalapura BN, Witvliet M, Jacobs AAC, et al. A novel intradermal combination vaccine for PCV2 and Mycoplasma hyopneumoniae protection in swine: its use with Lawsonia intracellularis and PRRSV vaccines. Porcine Health Manag. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40082953/

[34] Fourie KR, Chand DJ, Jeffery A, et al. Impact of adjuvants on innate and adaptive immune responses to Lawsonia intracellularis antigens in pigs when administered via the intradermal route. Vet Immunol Immunopathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41707436/

[35] Bakhsh M, Senevirathne A, Lee JH. A low-endotoxic Salmonella vector with dual bacterial-host promoter expression of Lawsonia intracellularis antigens elicits protective immunity in a murine model. Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41865004/